Form 8-K - Current report:
SEC Accession No. 0001023024-05-000010
Filing Date
2005-05-16
Accepted
2005-05-16 11:53:14
Documents
3
Period of Report
2005-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOSANTE !ST QUARTER 2005 EARNINGS RELEASE biosanteq1.htm 8-K 27075
2 BIOSANTE PHARMA EARNINGS PRESS RELEASE 5/16/05 pressrelease5-16.htm EX-99.1 15936
3 BIOSANTE LOGO biosantelogo6.jpg GRAPHIC 12999
  Complete submission text file 0001023024-05-000010.txt   62724
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 05832304
SIC: 2836 Biological Products, (No Diagnostic Substances)